Lopinavir/Ritonavir Pharmacokinetics in HIV/HCV-Coinfected Patients With or Without Cirrhosis

Liver disease may alter the pharmacokinetics of antiretrovirals and produce changes in plasma protein binding. The aim was to evaluate the pharmacokinetics of total and unbound lopinavir (LPV) in HIV-infected patients with and without hepatitis C virus (HCV) coinfection. Fifty-six HIV+ patients rece...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Micheli, Valeria, Regazzi, Mario, Dickinson, Laura, Meraviglia, Paola, Villani, Paola, Khoo, Saye H., Viganò, Paolo, Cordier, Laura, Cusato, Maria, Duca, Piergiorgio, Orlando, Giovanna, Rizzardini, Giuliano, Back, David J., Cargnel, Antonietta
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2008
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3672992/
https://ncbi.nlm.nih.gov/pubmed/18520602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FTD.0b013e318177209e
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller